SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-24-068319
Filing Date
2024-06-04
Accepted
2024-06-04 17:13:41
Documents
1
Period of Report
2024-06-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2416365-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2416365-1_4seq1.xml 4 4491
  Complete submission text file 0001104659-24-068319.txt   6083
Mailing Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054
Business Address 7707 FANNIN ST. SUITE 140 HOUSTON TX 77054 832-968-4888
Kiromic Biopharma, Inc. (Issuer) CIK: 0001792581 (see all company filings)

IRS No.: 464762913 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O KIROMIC BIOPHARMA, INC. 7707 FANNIN STREET, SUITE 140 HOUSTON TX 77054
Business Address
Ralston Shannon (Reporting) CIK: 0002023708 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39619 | Film No.: 241019333